Search Results - "Plésiat, P"

Refine Results
  1. 1
  2. 2

    Mutations in β-Lactamase AmpC Increase Resistance of Pseudomonas aeruginosa Isolates to Antipseudomonal Cephalosporins by Berrazeg, M, Jeannot, K, Ntsogo Enguéné, Véronique Yvette, Broutin, I, Loeffert, S, Fournier, D, Plésiat, P

    Published in Antimicrobial agents and chemotherapy (01-10-2015)
    “…Mutation-dependent overproduction of intrinsic β-lactamase AmpC is considered the main cause of resistance of clinical strains of Pseudomonas aeruginosa to…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Microbiological and Epidemiological Features of Clinical Respiratory Isolates of Burkholderia gladioli by Segonds, Christine, Clavel-Batut, Patricia, Thouverez, Michelle, Grenet, Dominique, Le Coustumier, Alain, Plésiat, Patrick, Chabanon, Gérard

    Published in Journal of Clinical Microbiology (01-05-2009)
    “…Burkholderia gladioli, primarily known as a plant pathogen, is involved in human infections, especially in patients with cystic fibrosis (CF). In the present…”
    Get full text
    Journal Article
  5. 5

    Evaluation of the Reveal® rapid AST system to assess the susceptibility of Pseudomonas aeruginosa from blood cultures by Couchot, J., Fournier, D., Bour, M., Rajeev, L., Rhodes, P., Singh, P., Jeannot, K., Plésiat, P.

    “…This study was set up to assess the performance of the Reveal® rapid AST system to determine the drug susceptibility of Pseudomonas aeruginosa strains directly…”
    Get full text
    Journal Article
  6. 6

    Detection of carbapenemase activity in Pseudomonas aeruginosa by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry (MALDI-TOF MS) by Miltgen, G., Plésiat, P., Mille, A., Chatelain, P., Fournier, D.

    Published in Journal of microbiological methods (01-02-2018)
    “…A new MALDI-TOF MS imipenem hydrolysis assay was developed to optimize detection of carbapenemase-producing strains of Pseudomonas aeruginosa. The method…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Pseudomonas aeruginosa: resistance and therapeutic options at the turn of the new millennium by Mesaros, N., Nordmann, P., Plésiat, P., Roussel-Delvallez, M., Van Eldere, J., Glupczynski, Y., Van Laethem, Y., Jacobs, F., Lebecque, P., Malfroot, A., Tulkens, P.M., Van Bambeke, F.

    Published in Clinical microbiology and infection (01-06-2007)
    “…Pseudomonas aeruginosa is a major cause of nosocomial infections. This organism shows a remarkable capacity to resist antibiotics, either intrinsically…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13

    Molecular epidemiology of multidrug-resistant Pseudomonas aeruginosa in a French university hospital by Cholley, P, Gbaguidi-Haore, H, Bertrand, X, Thouverez, M, Plésiat, P, Hocquet, D, Talon, D

    Published in The Journal of hospital infection (01-12-2010)
    “…Summary The aim of this study was to assess the incidence and molecular epidemiology of multidrug-resistant (MDR) Pseudomonas aeruginosa in our university…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16
  17. 17

    Emergence of extensive-drug-resistant Pseudomonas aeruginosa in a French university hospital by Vettoretti, L., Floret, N., Hocquet, D., Dehecq, B., Plésiat, P., Talon, D., Bertrand, X.

    “…The aim of this study was to describe the molecular epidemiology and the mechanisms of resistance to β-lactams of emerging extensive-drug-resistant Pseudomonas…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Elizabethkingia anophelis outbreak in France by Guerpillon, B., Fangous, M.S., Le Breton, E., Artus, M., le Gall, F., Khatchatourian, L., Talarmin, J.P., Plesiat, P., Jeannot, K., Saidani, N., Rolland-Jacob, G.

    Published in Infectious diseases now (Online) (01-08-2022)
    “…•Elizabethkingia anophelis was responsible for a high mortality rate outbreak.•A common environmental reservoir was suspected.•Treatment can be difficult and…”
    Get full text
    Journal Article
  20. 20